BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xu WD, Huang AF. Role of Interleukin-38 in Chronic Inflammatory Diseases: A Comprehensive Review. Front Immunol 2018;9:1462. [PMID: 29988385 DOI: 10.3389/fimmu.2018.01462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Tsilioni I, Pantazopoulos H, Conti P, Leeman SE, Theoharides TC. IL-38 inhibits microglial inflammatory mediators and is decreased in amygdala of children with autism spectrum disorder. Proc Natl Acad Sci U S A 2020;117:16475-80. [PMID: 32601180 DOI: 10.1073/pnas.2004666117] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
2 Wu Z, Mehrabi Nasab E, Arora P, Athari SS. Study effect of probiotics and prebiotics on treatment of OVA-LPS-induced of allergic asthma inflammation and pneumonia by regulating the TLR4/NF-kB signaling pathway. J Transl Med 2022;20:130. [PMID: 35296330 DOI: 10.1186/s12967-022-03337-3] [Reference Citation Analysis]
3 Esmaeilzadeh A, Bahmaie N, Nouri E, Hajkazemi MJ, Zareh Rafie M. Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study. Int J Mol Sci 2021;22:12552. [PMID: 34830435 DOI: 10.3390/ijms222212552] [Reference Citation Analysis]
4 Wooff Y, Man SM, Aggio-Bruce R, Natoli R, Fernando N. IL-1 Family Members Mediate Cell Death, Inflammation and Angiogenesis in Retinal Degenerative Diseases. Front Immunol 2019;10:1618. [PMID: 31379825 DOI: 10.3389/fimmu.2019.01618] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 15.3] [Reference Citation Analysis]
5 Murrieta-Coxca JM, Rodríguez-Martínez S, Cancino-Diaz ME, Markert UR, Favaro RR, Morales-Prieto DM. IL-36 Cytokines: Regulators of Inflammatory Responses and Their Emerging Role in Immunology of Reproduction. Int J Mol Sci 2019;20:E1649. [PMID: 30987081 DOI: 10.3390/ijms20071649] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
6 Behzadi P, Sameer AS, Nissar S, Banday MZ, Gajdács M, García-perdomo HA, Akhtar K, Pinheiro M, Magnusson P, Sarshar M, Ambrosi C, Cavaliere C. The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs). Journal of Immunology Research 2022;2022:1-25. [DOI: 10.1155/2022/2054431] [Reference Citation Analysis]
7 Wei Q, Chen X, Chen X, Yuan Z, Wang C. Contribution of IL-38 in Lung Immunity during Pseudomonas Aeruginosa-induced Pneumonia. Shock 2022;57:703-13. [PMID: 35583912 DOI: 10.1097/SHK.0000000000001919] [Reference Citation Analysis]
8 Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circ Res 2020;126:1260-80. [PMID: 32324502 DOI: 10.1161/CIRCRESAHA.120.315937] [Cited by in Crossref: 98] [Cited by in F6Publishing: 54] [Article Influence: 49.0] [Reference Citation Analysis]
9 Chai YS, Lin SH, Zhang M, Deng L, Chen Y, Xie K, Wang CJ, Xu F. IL-38 is a biomarker for acute respiratory distress syndrome in humans and down-regulates Th17 differentiation in vivo. Clin Immunol 2020;210:108315. [PMID: 31756565 DOI: 10.1016/j.clim.2019.108315] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Bonfigli AR, Protic O, Olivieri F, Montesanto A, Malatesta G, Di Pillo R, Antonicelli R. Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial. Trials 2020;21:616. [PMID: 32631422 DOI: 10.1186/s13063-020-04551-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Han MM, Yuan XR, Shi X, Zhu XY, Su Y, Xiong DK, Zhang XM, Zhou H, Wang JN. The Pathological Mechanism and Potential Application of IL-38 in Autoimmune Diseases. Front Pharmacol 2021;12:732790. [PMID: 34539413 DOI: 10.3389/fphar.2021.732790] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Mahmoud Marie RE, Adel AM, Abd El-Fadeal NM, Eyada MMK. Interleukin 38 serum level is increased in patients with vitiligo, correlated with disease severity, and associated with signs of disease activity. J Cosmet Dermatol 2021. [PMID: 34783147 DOI: 10.1111/jocd.14612] [Reference Citation Analysis]
13 Zhu J, Zhang J, Wang Y, Chen J, Li X, Liu X, Kong E, Su SB, Zhang Z. The Effect of Interleukin 38 on Inflammation-induced Corneal Neovascularization. Curr Mol Med 2019;19:589-96. [PMID: 31244436 DOI: 10.2174/1566524019666190627122655] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Zarrabi M, Nazarinia M, Rahimi Jaberi A, Gholijani N, Amirghofran Z. Elevated IL-38 Serum Levels in Newly Diagnosed Multiple Sclerosis and Systemic Sclerosis Patients. Med Princ Pract 2021;30:146-53. [PMID: 33080590 DOI: 10.1159/000510915] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Fazeli P, Saeidnia M, Erfani M, Kalani M. An overview of the biological and multifunctional roles of IL-38 in different infectious diseases and COVID-19. Immunol Res 2022. [PMID: 35260945 DOI: 10.1007/s12026-022-09275-y] [Reference Citation Analysis]
16 Esmaeilzadeh A, Pouyan S, Erfanmanesh M. Is Interleukin-38 a key player cytokine in atherosclerosis immune gene therapy? Med Hypotheses 2019;125:139-43. [PMID: 30902143 DOI: 10.1016/j.mehy.2019.02.048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
17 Sun X, Hou T, Cheung E, Iu TN, Tam VW, Chu IM, Tsang MS, Chan PK, Lam CW, Wong CK. Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma. Cell Mol Immunol 2020;17:631-46. [PMID: 31645649 DOI: 10.1038/s41423-019-0300-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]